Fungaemia and disseminated infection

Author(s):  
Rebecca Lester ◽  
John Rex

Invasive fungal disease can present without localization or obvious target organ involvement. These disseminated mycoses occur predominantly in patients who are immunocompromised, particularly from haematological malignancy and HIV. Candidiasis and aspergillosis are the commonest forms of disseminated fungal infection worldwide, but an increasing number of non-Candida yeasts and non-Aspergillus moulds have emerged as important causes of invasive disease in recent years. Endemic fungi such as Histoplasma capsulatum are important causes of invasive disease within limited geographic regions. Fever is the commonest manifestation of disseminated fungal infection, but other clinical features such as cutaneous manifestations may point to a specific diagnosis. Definitive diagnosis relies on the detection of fungi in tissue or blood, but serological tests can augment diagnosis in some infections. Mortality from disseminated fungal disease is high and prompt initiation of antifungal therapy—where invasive disease is suspected—is essential.

Author(s):  
Joanne Cleverley

The imaging of fungal infection is diverse and often non-specific with multiple abnormalities commonly identified, frequently with more than one organ involved. By correlating the clinical information, which should include patient immune status, pre-existing chronic disease, and potential exposure to endemic fungi, and using this information with an awareness of the radiographic findings of fungal infection, a potential diagnosis can be ascertained. In this chapter, the imaging of fungal infection is discussed, concentrating on the various imaging modalities available, their role, and the major organs involved, highlighting any distinguishing radiographic findings, which may help in the search for a definitive diagnosis.


Author(s):  
Shila Seaton ◽  
Rohini J. Manuel

The field of fungal diagnostics encompasses tests that are performed to help diagnose fungal disease, guide its management, and or monitor the effectiveness of its treatment. For some superficial skin and yeast infections, a clinical examination of the patient combined with microscopic examination of the sample may be sufficient to determine that fungal disease is present, even if the specific fungal pathogen is not identified. For deep- seated and systemic infections, a combination of diagnostic tests may be required in order to obtain a definitive diagnosis. These include microscopy to detect fungal elements, culture, detection of circulating antigens and antibodies, and molecular tests. More recently, molecular and proteomic approaches have increasingly dominated the conventional identification of pathogenic yeasts and, to some extent, filamentous fungi, since traditional methods are time consuming. More importantly, conventional methodologies have failed to identify common organisms that display uncharacteristic profiles, or fungal pathogens that are rarely encountered. The ‘gold standard’ for the definitive diagnosis of fungal disease is histology or culture of the fungal pathogen from a clinical specimen. A specimen will routinely be inoculated onto several different types of media, and then incubated at specific conditions and temperatures for up to twenty-one days. Media plates will be examined periodically for growth, and staff will try to identify the fungus using both macroscopic and microscopic morphologies. The few biochemical tests available, e.g. the urease test, can be helpful in identification, most often for yeast species. Microscopy of fungal isolates, histopathological examination of tissue, and fungal specific stains play fundamental roles in the diagnosis of infection for the variety of fungi that cause disease. The most common stain for identifying fungal elements from a cultured isolate is lactophenol fuschin/aniline blue stain. Figure 10.1 depicts the fruiting body (conidiophore) of Aspergillus fumigatus species complex, the most prevalent fungal species responsible for invasive aspergillosis (IA) in severely immunocompromised individuals. Figure 10.2 illustrates the phenotype of a three-day old colony. Serological tests are beneficial when non-culture based diagnosis of fungal disease is required. Complement fixation is predominantly used to diagnose endemic mycoses, e.g. coccidioidomycosis, blastomycosis, and histoplasmosis.


2008 ◽  
Vol 27 (8) ◽  
pp. 850-855 ◽  
Author(s):  
Fernanda P. Silveira ◽  
Eun J. Kwak ◽  
David L. Paterson ◽  
Joseph M. Pilewski ◽  
Kenneth R. McCurry ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-5 ◽  
Author(s):  
Ian A. Myles ◽  
Satyen Gada

Patients with HIV/AIDS can present with multiple types of fungal rhinosinusitis, fungal balls, granulomatous invasive fungal rhinosinusitis, acute or chronic invasive fungal rhinosinusitis, or allergic fungal rhinosinusitis (AFRS). Given the variable spectrum of immune status and susceptibility to severe infection from opportunistic pathogens it is extremely important that clinicians distinguish aggressive fungal invasive fungal disease from the much milder forms such as AFRS. Here we describe a patient with HIV and AFRS to both remind providers of the importance of ruling out invasive fungal disease and outline the other unique features of fungal sinusitis treatment in the HIV-positive population. Additionally we discuss the evidence for and against use of allergen immunotherapy (AIT) for fungal disease in general, as well as the evidence for AIT in the HIV population.


2003 ◽  
Vol 22 (1) ◽  
pp. S193 ◽  
Author(s):  
M.L Plit ◽  
L.G Singleton ◽  
A Scott ◽  
S Rainer ◽  
M.A Malouf ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document